Notably, BRCC3 mutations underlie severe hemophilia A and moyamoya (SHAM) syndrome, while MECP2 duplications are responsible for MECP2 duplication syndrome, both demonstrating the critical role of X-linked genomic stability in cerebrovascular pathology [94,95,102,103]. Here, MECP2 is linked to hemophilia A.